A Collaborative Effort: How Parallel Approaches And Diverse Partnerships Could Help Combat COVID-19

Source: Catalent

The COVID-19 virus is arguably the most challenging global healthcare crisis of our time. In a panel discussion, executives from Moderna, Sanofi Pasteur, Takeda, and Catalent shared behind-the-scenes updates on their respective efforts to develop a COVID-19 vaccine. While their approaches are different, the companies have all adopted a collaborative mindset to arrive at a vaccine as quickly and safely as possible.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online